Dn B Asset Management As Ionis Pharmaceuticals Inc Transaction History

Dn B Asset Management As

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 06, 2021	SELL	$34.54 - $47.25 $1.96 Million - $2.68 Million	-56,658 Closed	0 $0
Q1 2021 Apr 15, 2021	BUY	$42.51 - $63.78 $1.37 Million - $2.06 Million	32,277 Added 132.39%	56,658 $2.55 Million
Q4 2020 Jan 19, 2021	BUY	$45.3 - $60.27 $428,492 - $570,093	9,459 Added 63.39%	24,381 $1.38 Million
Q2 2020 Jul 08, 2020	BUY	$46.85 - $61.05 $79,457 - $103,540	1,696 Added 12.82%	14,922 $880 Million
Q1 2020 Apr 17, 2020	SELL	$41.6 - $63.4 $110,780 - $168,834	-2,663 Reduced 16.76%	13,226 $625,000
Q4 2019 Jan 13, 2020	BUY	$53.85 - $65.27 $86,160 - $104,432	1,600 Added 11.2%	15,889 $959,000
Q3 2019 Oct 16, 2019	BUY	$59.06 - $72.15 $42,582 - $52,020	721 Added 5.31%	14,289 $856,000
Q2 2019 Jul 08, 2019	BUY	$62.09 - $86.14 $842,437 - $1.17 Million	13,568 New	13,568 $0

394

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.99B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

Stay updated on Dn B Asset Management As with notifications on news.